Episode 9: Zogenix, Inc.'s Dawn Blessing and J. Michael Graglia from SynGAP

Episode 9 • September 01, 2021 • 00:47:27
Episode 9:  Zogenix, Inc.'s Dawn Blessing and J. Michael Graglia from SynGAP
Few & Far Between: How Biotech Gets Built
Episode 9: Zogenix, Inc.'s Dawn Blessing and J. Michael Graglia from SynGAP

Sep 01 2021 | 00:47:27

/

Show Notes

Tune in for today's full episode of Few & Far Between. Episode 9 features Biorasi's Becky Knockemus, Zogenix, Inc.'s Dawn Blessing, and J. Michael Graglia from SynGAP Research Fund, discussing the importance of diagnosing #raredisease early and the critical step of sharing study data.

Other Episodes

Episode 54

May 28, 2025 • 00:45:11
Episode Cover

Episode 54, Part One: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics

The challenge? Decoding the human immune system. Get ready to meet the top challenger on today's episode of the Biorasi Few & Far Between...

Listen

Episode 56

July 15, 2025 • 00:39:28
Episode Cover

Episode 56, Part Two: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics

How do experienced troubleshooters solve a difficult problem? By asking the right questions first! Welcome back to part two of our conversation with Michael...

Listen

Episode 44

October 23, 2024 • 00:44:29
Episode Cover

Episode 44: Jonathan Scheiman, PhD, Co-Founder and CEO at FitBiomics

"We don't endeavor to make elite athletes better. We endeavor to make society healthier." - Jonathan Scheiman, PhD, Co-Founder and CEO at FitBiomics Welcome...

Listen